Aggregation: Why Some Peptides Will Not Stay in Solution
Some peptides dissolve readily and stay dissolved. Others come into solution and then, over minutes or days, come back out of it. The difference is largely written into the sequence, and it is worth recognising before a solution is prepared rather than after it turns cloudy.
What aggregation is
Peptide molecules in solution interact with solvent and with each other. Where the interaction between molecules is more favourable than the interaction with solvent, they associate: first into small soluble oligomers, then into larger assemblies, and eventually into visible particulate that settles or films the vial wall.
The process is often nucleated. Nothing happens for a period, then association accelerates once a seed has formed, which is why a solution can look fine for hours and then change quickly.
What makes a sequence prone to it
- Hydrophobic content. Long stretches of non-polar residues prefer each other’s company to water’s. Sequences rich in valine, isoleucine, leucine and phenylalanine aggregate more readily.
- Beta-sheet propensity. Sequences that can hydrogen-bond into extended sheets stack efficiently, and the resulting assemblies are stable and hard to reverse.
- Low net charge at working pH. Charge keeps molecules apart through repulsion. A peptide carrying little net charge has less of that protection, which is why solubility is frequently at its worst near the isoelectric point.
- Length. Short peptides aggregate less, simply because there is less surface to associate.
What accelerates it
Concentration is the dominant variable: association is a multi-molecule event, so its rate rises steeply as molecules get closer together. A stock prepared at high concentration can aggregate while the same material at a tenth of that concentration does not.
Agitation matters more than people expect. Vortexing and shaking create air-liquid interfaces, and peptides adsorb and partially unfold at those interfaces, which seeds further association. Gentle swirling dissolves material with less of that effect than vigorous mixing.
Temperature cuts both ways. Warmth increases solubility for many sequences while also increasing the rate of association, so warming a cloudy solution sometimes clears it and sometimes accelerates the problem. Freeze-thaw is reliably unhelpful: ice formation concentrates the remaining liquid phase, which is precisely the condition aggregation favours.
How it appears analytically
On a reversed-phase chromatogram, soluble aggregates may elute as broad late peaks, or not elute at all if they are retained on the column. Insoluble material is filtered out before injection and simply vanishes from the analysis — which means the purity figure describes what remained in solution rather than what was in the vial.
Size-exclusion chromatography separates by hydrodynamic size and is the method suited to seeing oligomers as oligomers. It is not part of routine identity and purity characterisation. Column chemistry covers what reversed-phase retention depends on, and disulfide bonds covers the related case of intermolecular bridging producing covalent dimers.
Handling implications
Prepare at the concentration the work needs rather than the highest the vial allows, dissolve gently, and inspect against light before use. Choosing a reconstitution solvent covers the solvent decision, and aliquoting and vial entry covers limiting how often material is disturbed.
All material is supplied for laboratory research use only. It is not a drug, not a supplement, and not for use in humans or animals.
